Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Decibel Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
DBTX is no longer listed, and 13F filings after Q2 2023 list far fewer holders. See Q2 2023
- Institutional holders
- 1
- −36 vs. Q2 2023
- Shares held
- 40.0K
- −15.3M (−99.7%) vs. Q2 2023
- Total value
- $36.4K
- −$59.2M (−99.9%) vs. Q2 2023
- New holders
- 0
- 1 more added
- Sold out
- 36
- 0 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $36.4K |
| Q3 2023 | 1 | $36.4K |
| Q2 2023 | 37 | $59.2M |
| Q1 2023 | 38 | $46.7M |
| Q4 2022 | 39 | $35.8M |
| Q3 2022 | 40 | $62.1M |
| Q2 2022 | 42 | $75.2M |
| Q1 2022 | 39 | $53.8M |
| Q4 2021 | 40 | $81.7M |
| Q3 2021 | 36 | $145.9M |
| Q2 2021 | 46 | $168.1M |
| Q1 2021 | 54 | $226.3M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Capital Advisors LLC | 40,000 | $36.4K | 0.01% | +15,000+60.0% | Added |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −4,945,192−100.0% | Sold out |
| TRV GP III, LLC | 0 | $0 | 0.00% | −3,139,685−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −1,811,483−100.0% | Sold out |
| Alphabet Inc. | 0 | $0 | 0.00% | −1,636,258−100.0% | Sold out |
| Samsara BioCapital, LLC | 0 | $0 | 0.00% | −801,629−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −642,325−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −494,071−100.0% | Sold out |
| Harvard Management Co Inc | 0 | $0 | 0.00% | −326,029−100.0% | Sold out |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −199,200−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −159,224−100.0% | Sold out |
| Bronte Capital Management Pty Ltd. | 0 | $0 | 0.00% | −154,878−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −132,000−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −119,100−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −116,981−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −115,567−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −58,800−100.0% | Sold out |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −41,960−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −40,960−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −40,489−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −34,607−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −34,400−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −19,091−100.0% | Sold out |
| Baird Financial Group, Inc. | 0 | $0 | 0.00% | −14,900−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −11,990−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −10,855−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −10,600−100.0% | Sold out |
| Flagship Harbor Advisors, LLC | 0 | $0 | 0.00% | −10,113−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −6,600−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −3,970−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,867−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,735−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −722−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |